4.925

4.12% 0.195

Evolent Health Inc (EVH)

Overview News Price History Option Chain Financials Discussions Forecast

Evolent Health Inc stock is traded at $4.925, with a volume of 1.63M. It is up +4.12% in the last 24 hours and up +31.68% over the past month. Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The solutions provided by the company includes: Oncology, Cardiology, Musculoskeletal, Administrative Services, Advanced Illness, Genetic Testing, Physical Medicine, Radiology, and Surgical Management.

Previous Close:

$4.73

Open:

$4.75

24h Volume:

1.63M

Relative Volume:

0.84

Market Cap:

$556.82M

Revenue:

$1.89B

Net Income/Loss:

$-496.52M

P/E Ratio:

-1.0347

EPS:

-4.7598

Net Cash Flow:

$1.40M

1W Performance:

+24.37%

1M Performance:

+31.68%

6M Performance:

+71.01%

1Y Performance:

-37.18%

1-Day Range:

$4.75

$5.115

1-Week Range:

$3.98

$4.76

52-Week Range:

$2.095

$8.30

Evolent Health Inc Stock (EVH) Company Profile

Name

Evolent Health Inc

Sector

Healthcare (1051)

Industry

Health Information Services (41)

Phone

571-389-6000

Address

1812 NORTH MOORE ST, SUITE 1705, ARLINGTON

Employee

4,200

Twitter

@EvolentHealth

Next Earnings Date

2026-11-05

Latest SEC Filings

EVH's Discussions on Twitter

Compare EVH vs VEEV, TEM, BTSG, HNGE, HQY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EVH Evolent Health Inc	4.925	556.82M	1.89B	-496.52M	1.40M	-4.7598
VEEV Veeva Systems Inc	312.57	50.61B	3.32B	941.65M	1.64B	5.6161
TEM Tempus Ai Inc	69.23	12.57B	1.36B	-302.91M	-219.93M	-1.7182
BTSG Brightspring Health Services Inc	62.40	12.35B	13.65B	169.86M	412.12M	1.0758
HNGE Hinge Health Inc	105.15	8.48B	646.34M	-512.40M	202.76M	-6.6871
HQY Healthequity Inc	92.58	7.66B	1.34B	230.70M	440.96M	2.6695

Evolent Health Inc Stock (EVH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-11-26	Upgrade	Citigroup	Neutral → Buy
Jul-23-26	Downgrade	Citigroup	Buy → Sell
Jun-30-26	Downgrade	Truist	Buy → Hold
Feb-25-26	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Nov-13-25	Initiated	BMO Capital Markets	Outperform
Nov-13-25	Upgrade	Stephens	Equal-Weight → Overweight
Jan-10-25	Initiated	Needham	Buy
Dec-03-24	Reiterated	BTIG Research	Buy
Nov-08-24	Downgrade	Stephens	Overweight → Equal-Weight
Oct-11-24	Initiated	KeyBanc Capital Markets	Overweight
Aug-09-24	Upgrade	Truist	Hold → Buy
Apr-22-24	Initiated	Citigroup	Buy
Mar-01-24	Initiated	Oppenheimer	Outperform
Jan-03-24	Initiated	Barclays	Overweight
Dec-06-23	Initiated	JMP Securities	Mkt Outperform
Oct-16-23	Initiated	UBS	Buy
Apr-12-23	Initiated	Stephens	Overweight
Nov-01-22	Initiated	Truist	Hold
Jul-29-22	Initiated	RBC Capital Mkts	Outperform
Mar-30-22	Initiated	Guggenheim	Buy
Nov-18-21	Upgrade	JP Morgan	Neutral → Overweight
Apr-29-21	Resumed	JP Morgan	Neutral
Jan-07-21	Initiated	BTIG Research	Buy
Jul-06-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Jun-05-20	Downgrade	Goldman	Buy → Neutral
Jun-02-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Oct-05-18	Resumed	Leerink Partners	Outperform
Jun-04-18	Initiated	Piper Jaffray	Overweight
Apr-24-18	Resumed	JP Morgan	Neutral
Sep-20-17	Initiated	KeyBanc Capital Mkts	Overweight
Jun-02-17	Initiated	Robert W. Baird	Outperform
Mar-14-17	Initiated	Oppenheimer	Outperform
Jan-13-17	Upgrade	Wells Fargo	Market Perform → Outperform
Oct-28-16	Resumed	JP Morgan	Overweight
Aug-05-16	Reiterated	FBR Capital	Outperform
Jul-26-16	Initiated	Jefferies	Buy
Jul-13-16	Reiterated	FBR Capital	Outperform
Mar-29-16	Initiated	FBR Capital	Outperform
Jan-06-16	Initiated	Canaccord Genuity	Buy
Jun-30-15	Initiated	Goldman	Buy
Jun-30-15	Initiated	JP Morgan	Overweight
Jun-30-15	Initiated	Leerink Partners	Outperform
Jun-30-15	Initiated	Sun Trust Rbsn Humphrey	Buy

View All

Evolent Health Inc Stock (EVH) Latest News

Sep 09, 2026

Evolent program flags low-value regimen years ahead of failed clinical trial - RamaOnHealthcare

Sep 09, 2026

Sep 08, 2026

Evolent Health President Daniel Joseph McCarthy sells 65,892 shares for $329,460 - Bitget

Aug 28, 2026

Aug 27, 2026

EVH6495551 Bond Yield and Price — FINRA:EVH6495551 - TradingView

Aug 27, 2026

Evolent Health (EVH) Institutional Ownership 2026 $EVH - MarketBeat

Aug 27, 2026

Aug 26, 2026

Evolent Health (NYSE: EVH) officer lines up 2026 stock sale - Stock Titan

Aug 26, 2026

Aug 23, 2026

EVH | Evolent Health, Inc Class FinancialsRevenue Breakdown - quiverquant.com

Aug 23, 2026

Aug 18, 2026

EVH Maintains Overweight Rating by JP Morgan -- Price Target Rai - GuruFocus

Aug 18, 2026

Aug 17, 2026

EVH Maintained by TD Cowen -- Price Target Raised to $6.00 - GuruFocus

Aug 17, 2026

TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $6 - Moomoo

Aug 17, 2026

Aug 16, 2026

TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Raises Target Price to $6 - Moomoo

Aug 16, 2026

1 Healthcare Stock Worth Your Attention and 2 We Brush Off - Yahoo Finance UK

Aug 16, 2026

Aug 15, 2026

1 Healthcare Stock Worth Your Attention and 2 We Brush Off - Yahoo Finance

Aug 15, 2026

Aug 14, 2026

5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call - Yahoo Finance

Aug 14, 2026

Aug 13, 2026

Evolent Health (NYSE:EVH) Shares Up 10%What's Next? - marketbeat.com

Aug 13, 2026

Evolent Health (EVH) Q2 2026 Earnings Call Transcript - The Globe and Mail

Aug 13, 2026

Evolent Health rated Buy despite heavy debt and losses, betting on strong growth by 2027. - Pluang

Aug 13, 2026

Evolent Health Q2 Earnings Review: Debt Is Distressing, But Business Is Booming (EVH) - Seeking Alpha

Aug 13, 2026

Truist Financial Sticks to Their Hold Rating for Evolent Health (EVH) - The Globe and Mail

Aug 13, 2026

Dimensional Fund Advisors LP Has $4.08 Million Stock Position in Evolent Health, Inc $EVH - marketbeat.com

Aug 13, 2026

5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call - TradingView

Aug 13, 2026

Aug 12, 2026

EVH Maintained by Truist Securities -- Price Target Lowered to $6.00 - GuruFocus

Aug 12, 2026

Truist Financial Cuts Evolent Health (NYSE:EVH) Price Target to $6.00 - marketbeat.com

Aug 12, 2026

Truist Financial Maintains Evolent Health(EVH.US) With Hold Rating, Cuts Target Price to $6 - Moomoo

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Australia

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Nigeria

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com South Africa

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com India

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks - Investing.com

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com Canada

Aug 12, 2026

Truist cuts Evolent Health stock price target on execution risks By Investing.com - Investing.com UK

Aug 12, 2026

Truist Securities Adjusts Price Target on Evolent Health to $6 From $7, Keeps Hold Rating - marketscreener.com

Aug 12, 2026

Aug 11, 2026

Evolent Health Shares Rise After Citigroup Upgrade - marketscreener.com

Aug 11, 2026

EVH Upgraded by Citigroup -- Price Target Lowered to $6.00 - GuruFocus

Aug 11, 2026

EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget

Aug 11, 2026